Estimated Prevalence of Metastatic Breast Cancer in England, 2016-2021-Reference-Cited by-同舟云学术

Estimated Prevalence of Metastatic Breast Cancer in England, 2016-2021

Published:2022-12-22 Issue:12 Volume:5 Page:e2248069
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Palmieri Carlo¹²,Owide Joshua³,Fryer Kirsty³

Affiliation:

1. Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom

2. The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom

3. Wilmington Healthcare Ltd, London, United Kingdom

Abstract

This case series study provides an estimate of total cases of metastatic breast cancer in England based on National Health Service data.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2799862/palmieri_2022_ld_220289_1671050407.34442.pdf

Reference5 articles.

1. Estimating prevalence of distant metastatic breast cancer: a means of filling a data gap.;Clements;Cancer Causes Control,2012

2. Estimation of the number of women living with metastatic breast cancer in the United States.;Mariotto;Cancer Epidemiol Biomarkers Prev,2017

3. Projecting the prevalence and costs of metastatic breast cancer from 2015 through 2030.;Gogate;J Natl Cancer Inst Cancer Spectr,2021

4. National Health Service. Cancer Registration Statistics, England 2019. NHS Digital. October 21, 2021. Accessed August 3, 2022. https://digital.nhs.uk/data-and-information/publications/statistical/cancer-registration-statistics/england-2019

5. Breast Cancer Now. The unsurvivors: For those living with incurable secondary breast cancer, things need to change. October 2019. Accessed August 3, 2022. https://breastcancernow.org/sites/default/files/bcn_theunsurvivors_campaignreport_oct2019.pdf

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palbociclib in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer: A Systematic Scoping Review of Real-World Evidence from Countries Outside of Western Regions that Are Underrepresented in Clinical Trials;Oncology and Therapy;2024-08-02

2. A pragmatic qualitative study to explore women's and clinicians' experience of access to systemic anti-cancer therapies for the treatment of secondary breast cancer;European Journal of Oncology Nursing;2024-06

3. Case report: Poorly differentiated breast carcinoma presenting as a breast abscess;Radiology Case Reports;2024-06

4. Geographic and sociodemographic access to systemic anticancer therapies for secondary breast cancer: a systematic review;Systematic Reviews;2024-01-18

5. Development and validation of an algorithm to estimate incidence and prevalence of breast cancer patients with distant metastasis in Northern Ireland: A population-based study;2024-01-17